Chemical Watch News public
[search 0]
More
Download the App!
show episodes
 
Artwork

1
Chemical Watch News and Insight Podcast

Chemical Watch News and Insight by Enhesa

Unsubscribe
Unsubscribe
Monthly
 
Stay up to date with some of the biggest regulatory and chemical management stories from the last 30 days. Every month Chemical Watch News & Insight journalists will explain the background and significance of some of our key stories, giving you additional context and insight into the regulatory and chemical management developments affecting you, your team and your organisation.
  continue reading
 
Thanks for tuning in! I'm a medical doctor and Specialist in Endocrinology and Metabolism in Canada, and I'm also certified as a Diplomate of the American Board of Obesity Medicine. Why do I blog and podcast about weight management, obesity, and diabetes? Well, there is a LOT of misinformation out there, so I'm here to provide a resource that you (as a person/patient or as a health care provider) can trust! I bring to you hot topics, new science, and breaking news, with some mythbusting mixe ...
  continue reading
 
Artwork

1
EHS on Tap

EHS Daily Advisor

Unsubscribe
Unsubscribe
Monthly+
 
EHS On Tap is an environmental, health, and safety podcast by BLR. On each episode of EHS On Tap, host Jay Kumar will discuss emerging legal, regulatory, and policy issues with industry experts and the impacts to everyday environmental and safety professionals. EHS On Tap runs the gamut of contemporary environmental issues including water, air, and waste as well as covers a wide variety of safety issues.
  continue reading
 
Artwork

1
Nowhere to Hide

Global Public Policy Institute (GPPi)

Unsubscribe
Unsubscribe
Monthly
 
Piecing together one of the worst crimes in modern history: the use of chemical weapons in the Syrian war. For the first time, Nowhere to Hide tells extraordinary stories from those who came closest to these attacks and those who risked their lives to tell the world what was happening. From field hospitals in Aleppo to the boardrooms of the United Nations, from frontlines in Damascus to courtrooms across Europe, survivors, doctors, journalists, lawyers, diplomats and forensic investigators r ...
  continue reading
 
Loading …
show series
 
In this episode, Europe editor Luke Buxton walks us through the new UK REACH registration model ⁠proposal⁠, Asia desk editor Dr Kerry Hebden talks about why Japanese businesses want ⁠more time⁠ to phase out the flame retardant Dechlorane Plus, and North America desk editor Julia John shares the story behind how the UV-absorber ⁠BEMT⁠ could become f…
  continue reading
 
Some people may lose too much muscle with weight loss medication. In preventing or rebuilding lost muscle, which is more important - dietary protein or physical activity? Learn more: https://drsue.ca/2024/06/preventing-or-rebuilding-muscle-loss-from-weight-loss-medication-is-dietary-protein-or-exercise-more-important/ Any medical discussion on this…
  continue reading
 
Elevated weight can be a cause or contributor to hypertension. Why is it so important to watch your blood pressure if you are on weight management medication? Learn more: https://drsue.ca/2024/06/watching-blood-pressure-on-weight-loss-medication-why-is-this-important/ Any medical discussion on this podcast is intended to be of a general nature only…
  continue reading
 
Obesity: are environmental chemicals at the center of the storm? Find out where these chemicals may reside.... even in our nonstick cookware. Eeew. Learn more: https://drsue.ca/2024/05/obesity-are-environmental-chemicals-at-the-center-of-the-storm/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended fo…
  continue reading
 
We know that GLP1 medications reduce protein in the urine in people with type 2 diabetes and kidney disease, but no study had ever been done to see whether GLP1 treatment could protect kidney function – until now. Learn more: https://drsue.ca/2024/05/semaglutide-first-glp1-medication-proven-to-provide-kidney-protection/ Any medical discussion on th…
  continue reading
 
We know that GLP-1 receptor agonist medications reduce heart attack and stroke risk in people with diabetes, and in people with obesity. But what happens to risk of cardiovascular events if GLP-1 receptor agonist treatment is stopped? Learn more: https://drsue.ca/2024/05/does-heart-attack-and-stroke-risk-go-up-after-stopping-glp1-receptor-agonists/…
  continue reading
 
Wegovy (semaglutide for weight management) is now available in Canada! What do you need to know? Learn more: https://drsue.ca/2024/05/semaglutide-2-4mg-wegovy-for-weight-management-now-at-canadian-pharmacies/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is n…
  continue reading
 
As the global shortage of highly effective weight management and diabetes medications (Ozempic, Wegovy, Mounjaro, Zepbound) continues, who should get priority to new starts? Learn more: https://drsue.ca/2024/04/what-is-fair-allocation-of-glp1-based-medications-during-the-global-shortages/ Any medical discussion on this podcast is intended to be of …
  continue reading
 
As many as 1 BILLION adults worldwide are estimated to have obstructive sleep apnea (OSA), and 70% of people with OSA have obesity. How much does sleep apnea improve with weight loss, and does it matter how the weight is lost (with lifestyle, weight management medication, or bariatric surgery)? Learn more: https://drsue.ca/2024/04/how-much-does-sle…
  continue reading
 
This week's Chemical Watch News & Insight podcast takes a deep dive into a recent ruling from the US Court of Appeals for the Fifth Circuit in the case of Inhance Technologies v US EPA. In this episode, North America managing editor Kelly Franklin and senior editor Terry Hyland discuss the history and potentially broad implications of the court's c…
  continue reading
 
Semaglutide 2.4mg (Wegovy) has now been shown to effectively treat symptoms of heart failure in people with or without diabetes. What do the new data teach us? Learn more: https://drsue.ca/2024/04/weight-management-medication-semaglutide-wegovy-for-heart-failure-what-do-new-data-in-people-with-diabetes-teach-us/ Any medical discussion on this podca…
  continue reading
 
Older data have shown that obesity medications are prescribed far less frequently than medications for other chronic medical conditions. Much has changed in recent years in the weight management world. How has this impacted prescribing of weight management medication? Learn more: https://drsue.ca/2024/04/how-many-people-with-obesity-actually-receiv…
  continue reading
 
Articles have gone viral this week regarding women getting pregnant on diabetes/weight management GLP1-based medications, particularly semaglutide (Ozempic for diabetes, Wegovy for weight management) and tirzepatide (Mounjaro for diabetes, Zepbound for weight management). What do you need to know? Learn more: https://drsue.ca/2024/04/mounjaro-ozemp…
  continue reading
 
Oprah Winfrey recently hosted a special called 'Shame, Blame, and the Weight Loss Revolution'. What will the Oprah Effect be on obesity medicine? Learn more: https://drsue.ca/2024/03/what-will-the-oprah-effect-be-on-obesity-medicine/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian au…
  continue reading
 
Resmetirom is the first treatment ever approved for fatty liver disease. Could GLP1 based obesity/diabetes medications have similar benefits? Learn more: https://drsue.ca/2024/03/first-medication-ever-approved-to-treat-fatty-liver-disease-how-will-glp1-based-obesity-diabetes-medications-stack-up/ Any medical discussion on this podcast is intended t…
  continue reading
 
This week's Chemical Watch News & Insight podcast dives into some of the latest developments out of the European Commission, Taiwan and the US EPA. In this episode, senior correspondent for Europe Clelia Oziel discusses action behind the scenes as the European Commission debates the REACH revision, polymer registration, essential use of chemicals a…
  continue reading
 
With the emergence of medications that are very powerful for weight loss, some people may lose too much weight. This can include excessive loss of muscle mass, a condition called sarcopenia. How should we look for and diagnose sarcopenia? Learn more: https://drsue.ca/2024/03/how-can-we-diagnose-sarcopenia-excessive-loss-of-muscle-in-people-successf…
  continue reading
 
The DiRECT 5 year trial of diabetes remission with lifestyle was just published. Does this study suggest that we should 'DiRECT' our patients towards lifestyle treatment alone? Learn more: https://drsue.ca/2024/03/diabetes-remission-should-we-direct-patients-towards-lifestyle-change-alone/ Any medical discussion on this podcast is intended to be of…
  continue reading
 
Guidelines currently recommend lifestyle change as a strategy to achieve diabetes remission. But is diabetes remission with lifestyle change alone a realistic long term goal? Learn more: https://drsue.ca/2024/02/is-diabetes-remission-with-lifestyle-change-a-realistic-long-term-goal/ Any medical discussion on this podcast is intended to be of a gene…
  continue reading
 
Welcome to the second of three special editions focused on our 2024 Global Outlook series of articles produced by the Chemical Watch News & Insight team. In this episode, North America managing editor Kelly Franklin and Europe managing editor Leigh Stringer join senior editor Terry Hyland to discuss the outlook this year for TSCA in the US and chem…
  continue reading
 
Will glucagon with GLP-1 be a new combination weight management treatment? How could these 2 hormones work together to facilitate weight loss? Learn more: https://drsue.ca/2024/02/will-glucagon-with-glp1-be-a-new-combination-weight-management-treatment/ Any medical discussion on this podcast is intended to be of a general nature only, and is intend…
  continue reading
 
The Chemical Watch News & Insight podcast is back! Welcome to the first of three special editions focused on our 2024 Global Outlook series of articles produced by the Chemical Watch News & Insight team. In this episode, North America desk editor Julia John, transport and storage managing editor Peter Mackay, and Europe managing editor Leigh String…
  continue reading
 
There are many important strategies to protect the kidneys of people with type 2 diabetes. Could a longer time at a target weight loss be one of them? Learn more: https://drsue.ca/2024/02/could-spending-more-time-at-a-target-weight-protect-against-kidney-failure-in-people-with-type-2-diabetes/ Any medical discussion on this podcast is intended to b…
  continue reading
 
Rare post marketing case reports of suicidality have emerged amongst people taking GLP1 receptor agonists for diabetes or obesity. What new data do we have on this, and where are global regulatory agencies at in their investigations? Learn more: https://drsue.ca/2024/01/update-are-glp1-receptor-agonist-medications-for-weight-management-and-diabetes…
  continue reading
 
What are the risks associated with the RSV virus, and should you be vaccinated? Learn more: https://drsue.ca/2024/01/should-you-get-the-rsv-vaccine/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor…
  continue reading
 
Why do so many people stop weight management medication - and why does it matter? Learn more: https://drsue.ca/2024/01/why-do-so-many-people-stop-their-weight-management-medication/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specifi…
  continue reading
 
We know that elevated weight is a key risk factor for developing type 2 diabetes. Does carrying elevated weight increase the risk of developing autoimmune type 1 diabetes as well? Learn more: https://drsue.ca/2024/01/does-obesity-increase-the-risk-of-developing-autoimmune-type-1-diabetes/ Any medical discussion on this podcast is intended to be of …
  continue reading
 
Miss any key advancements and challenges in the field of weight management in 2023? Join me for the highlights here! Learn more: https://drsue.ca/2023/12/dr-sues-weight-management-highlights-2023/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed …
  continue reading
 
Loading …

Quick Reference Guide